Status:
WITHDRAWN
Implantation of an Advanced Practice Nurse in the Complex Care Pathway of Patients With AML
Lead Sponsor:
Centre Hospitalier Régional Metz-Thionville
Conditions:
Myeloid Leukemia
Eligibility:
All Genders
18+ years
Brief Summary
Advanced Practice Nurse (APN) is a new contributor in the French healthcare system. APN is part of a multidisciplinary team and aim to monitor patients under the coordination of the doctor particularl...
Eligibility Criteria
Inclusion
- Patient with AML
- Treated with a new targeted oral therapy as monotherapy or in combination:
- Venetoclax\* in combination with ivosidenib (IDH1 inhibitor)
- Onureg\* (azacitin: pyrimidine analogue)
- Venetoclax (BCL-2 protein inhibitor) in combination with subcutaneous azacitin
- Whose follow-up is provided alternately by a hematologist and an IPA.
- Affiliated to a social security scheme
Exclusion
- Moderate or severe cognitive impairment
- Language barrier
- Other communication disorders
Key Trial Info
Start Date :
May 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 15 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05309018
Start Date
May 15 2024
End Date
December 15 2024
Last Update
May 23 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.